These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21436214)

  • 1. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease.
    Mankaï A; Achour A; Thabet Y; Manoubia W; Sakly W; Ghedira I
    Pathol Biol (Paris); 2012 Oct; 60(5):291-5. PubMed ID: 21839587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA is the predominant isotype of anti-β2 glycoprotein I antibodies in rheumatoid arthritis.
    Melayah S; Changuel M; Mankaï A; Ghedira I
    J Clin Lab Anal; 2020 Jun; 34(6):e23217. PubMed ID: 31967351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome].
    Fujieda Y; Shida H; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(5):430-6. PubMed ID: 25744643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus.
    Gould T; Tikly M; Asherson R; Loizou S; Singh S
    Scand J Rheumatol; 2006; 35(1):29-34. PubMed ID: 16467038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three commercial ELISA kits for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Decavele AS; Schouwers S; Devreese KM
    Int J Lab Hematol; 2011 Feb; 33(1):97-108. PubMed ID: 20813022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA is the predominant isotype of anti-β2 glycoprotein I in patients with COVID-19.
    Melayah S; Omrani N; Alouini H; Ghozzi M; Mrad S; Boussarsar M; Chaouch H; Hachfi W; Letaief A; Mankaï A; Ghedira I
    Lab Med; 2024 May; 55(3):373-379. PubMed ID: 38124622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward harmonized interpretation of anticardiolipin and anti-β2-glycoprotein I antibody detection for diagnosis of antiphospholipid syndrome using defined level intervals and likelihood ratios: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2024 Aug; 22(8):2345-2362. PubMed ID: 38704123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of IgA antiphospholipid antibodies in diagnosis of the antiphospholipid syndrome].
    Yang B; Zhao JL; Huang ZC; Su ZZ; Li MT; Zeng XF; Hu CJ
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3404-3410. PubMed ID: 34758544
    [No Abstract]   [Full Text] [Related]  

  • 18. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I--Anticardiolipin and anti-β2-glycoprotein I antibodies.
    Favaloro EJ; Wheatland L; Jovanovich S; Roberts-Thomson P; Wong RC
    Semin Thromb Hemost; 2012 Jun; 38(4):390-403. PubMed ID: 22570184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
    Sebastiani GD; Galeazzi M; Tincani A; Piette JC; Font J; Allegri F; Mathieu A; Smolen J; de Ramon Garrido E; Fernandez-Nebro A; Jedryka-Goral A; Papasteriades C; Morozzi G; Bellisai F; De Pitá O; Marcolongo R
    Scand J Rheumatol; 1999; 28(6):344-51. PubMed ID: 10665739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients.
    Despierres L; Beziane A; Kaplanski G; Granel B; Serratrice J; Cohen W; Bretelle F; Rossi P; Morange PE; Weiller PJ; Robert Harlé J; Bongrand P; Bardin N
    Rheumatology (Oxford); 2014 Jul; 53(7):1215-8. PubMed ID: 24599915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.